RxDoctor Payments DataLook up a doctor →

James Stefater, MD

Ophthalmology · East Weymouth, MANPI 1427491000

Payments from drug & device makers

$374,541in general payments, 2019–2025

Across 182 payments — averaging $2057.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron$361K
  • Alcon Research LLC$6K
  • Merck$6K
  • Alcon$407
  • Beaver-visitec International, Inc.$144
  • Carl Zeiss Meditec, Inc.$129
  • plus $286 from 5 others
$1,304in research payments, 2019–2025

Across 9 payments — averaging $144.90 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Regeneron$1K

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$374,541 in reported general payments places this provider in the 95th percentile of 653 ophthalmology providers in Massachusetts.

See all ophthalmology providers in Massachusetts

Medicare billing

Part B allowed, 2024
$2,929,935
Medicare patients
989
Services billed
23,101

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other ophthalmology in East Weymouth

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →